RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Washington D.C., DC · +50 more sites
Lupus clinical trials in Washington D.C., DC
6 recruiting lupus studies with a site in Washington D.C., DC.
RecruitingPhase 3NCT05835310
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Sponsor: AstraZeneca
Washington D.C., DC · +21 more sites
RecruitingPhase 1 / Phase 2NCT07089121
Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Sponsor: Cartesian Therapeutics
Washington D.C., DC · +2 more sites
RecruitingPhase not listedNCT04833465
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
Sponsor: Children's National Research Institute
Washington D.C., DC
RecruitingPhase not listedNCT05934149
Lupus Landmark Study: A Prospective Registry and Biorepository
Sponsor: Lupus Research Alliance
Washington D.C., DC · +18 more sites
RecruitingPhase not listedNCT06927219
Research Accelerated by You Lupus Registry
Sponsor: Lupus Foundation of America
Washington D.C., DC
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.